首页 › 脂肪性肝病 › 加利福尼亚州 › Pasadena
Pasadena CA 脂肪性肝病临床试验
8项针对 脂肪性肝病的研究正在 Pasadena及周边约 30 英里内的站点招募参与者。打开研究详情可查看入选标准及联系研究团队的方式。
官方研究文本（英文）
正在为研究招募参与者？将此页面置顶展示 — $99 / 30天 →
A Study to Evaluate the Efficacy and Safety of Pegozafermin in Participants With Compensated Cirrhosis Due to MASH
招募中3 期
- 89bio Clinical Study Site, Pasadena
A Study Evaluating the Efficacy and Safety of Pegozafermin in Participants With MASH and Fibrosis (ENLIGHTEN-Fibrosis)
招募中3 期
- 89bio Clinical Study Site, Pasadena
A Phase 2a Study of ALN-PNP With and Without a GLP1R Agonist in Adult Patients With Homozygous PNPLA3-Related MASLD
招募中2 期
- California Liver Research Institute, Pasadena
A Precision Medicine Approach Using Gene Silencing to Treat a Chronic Liver Disease Called Metabolic Dysfunction-Associated Steatohepatitis (MASH) in Adult Participants at Increased Genetic Risk for This Condition
招募中2 期
- California Liver Research Institute, Pasadena
A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)
招募中3 期
- California Liver Research Center, Pasadena
A Study Evaluating Efruxifermin in Subjects With Compensated Cirrhosis Due to NASH/MASH
招募中3 期
- Akero Clinical Study Site, Pasadena
A Study to Investigate the Safety and Efficacy of GSK4532990 Compared With Placebo in Adult Participants Aged 18 to 70 Years With Alcohol-related Liver Disease
招募中2 期
- GSK Investigational Site, Pasadena
A Study of Efimosfermin Alfa in Participants With Biopsy-confirmed Cirrhosis (Compensated) Due to MASH
招募中2 期
- GSK Investigational Site, Pasadena
其他城市的 脂肪性肝病试验
- San Antonio, TX17 项研究
- Miami, FL16 项研究
- New York City, NY16 项研究
- San Diego, CA14 项研究
- Austin, TX13 项研究
- Houston, TX13 项研究
- Richmond, VA12 项研究
- Tucson, AZ10 项研究
- Chandler, AZ10 项研究
- Hialeah, FL9 项研究
- Orlando, FL9 项研究
- Dallas, TX9 项研究
Pasadena的其他研究
数据来自 ClinicalTrials.gov，检索日期：2026年10月6日。每项研究自行设定入选标准，由研究团队决定谁能参与。